ILLUMINA
Historically , NGS data required expert analysis , which presented a major hurdle to adoption of RNA-Seq technology . Illumina ’ s user-friendly innovations are solving this issue .
overseas and broaden its customer base in the country while also allowing it to capture a larger share of this multi-billion dollar market .
Leading the genomics revolution Illumina has truly been an impressive company from the start , and there is reason to believe that it will continue to reach new heights .
While its name is still barely recognizable to the public , Illumina is not only one of the most important companies in biomedicine but is also a leader in the field . With a history of producing innovative products and technologies over the span of 15 years , Illumina may soon claim the market all to itself .
As noted by Forbes , “ Just as Intel became the company that sparked so much of the computer revolution , Illumina has risen to prominence as a driver of the genomics revolution .”
13